D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

✓ Billable ICD-10-CM 2026
Open D68.318 in Web App →

The ICD-10-CM code for Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors is D68.318 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
D65-D69: Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
Category D68
32 codes (25 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D68.318:

  • Circulating anticoagulants
  • Anticoagulant, circulating (intrinsic)
  • Antithromboplastinogenemia
  • Antithromboplastinemia
  • Disorder (of) › hemorrhagic NEC › due to › intrinsic › circulating anticoagulants
  • Disorder (of) › hemorrhagic NEC › due to › intrinsic › increase in › anti-VIIIa
  • Disorder (of) › hemorrhagic NEC › due to › intrinsic › increase in › anti-XIa
  • Disorder (of) › hemorrhagic NEC › due to › intrinsic › increase in › anti-IXa

Inclusion Terms

  • Antithromboplastinemia
  • Antithromboplastinogenemia
  • Hemorrhagic disorder due to intrinsic increase in antithrombin
  • Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
  • Hemorrhagic disorder due to intrinsic increase in anti-IXa
  • Hemorrhagic disorder due to intrinsic increase in anti-XIa

U.S. Hospital Utilization

  • An estimated 1,495 U.S. inpatient stays in 2023 included D68.318 among the documented diagnoses.
  • 295 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Chapter 3 TOC entry

3. Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) ............................................................................................. 39

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.3
Reserved for future guideline expansion

Reserved for future guideline expansion ...................................................................................... 39

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.3.Reserved

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial